Emily Fairbairn

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Corvex Inc., 3 years.

Corvex Inc. Director
3 years ยท Since 2023
IN8bio Inc. Director
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 7, 2026 Corvex Inc. Derivative conversion +1,205,282 โ€” โ€”
Jul 1, 2026 Corvex Inc. Grant or award +135,800 โ€” โ€”
May 27, 2026 IN8bio Inc. Gift โˆ’724,637 โ€” โ€”
Mar 31, 2026 Corvex Inc. Derivative conversion +9,231 โ€” โ€”
Mar 16, 2026 Corvex Inc. Option exercise +55,250 $1.25 $69,063
Jan 9, 2026 Corvex Inc. Grant or award +4,470 โ€” โ€”
Jan 9, 2026 Corvex Inc. Grant or award +5,959 โ€” โ€”
Dec 22, 2025 IN8bio Inc. Grant or award +724,637 $1.38 $999,999
Nov 3, 2025 Corvex Inc. Sold back to the company โˆ’12,442 โ€” โ€”
Oct 3, 2025 Corvex Inc. Grant or award +31,028 โ€” โ€”
Jul 3, 2025 Corvex Inc. Grant or award +27,985 โ€” โ€”
May 9, 2025 Corvex Inc. Grant or award +65,407 โ€” โ€”
Apr 2, 2024 Corvex Inc. Open-market purchase +4,690,000 โ€” โ€”
Nov 14, 2023 Corvex Inc. Open-market purchase +295,000 $0.85 $250,750
Jul 28, 2023 IN8bio Inc. Other โˆ’4,111,958 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.